Dr. Martens said that the broker Goldman Sachs International exercised the over-allotment option granted by IngreLux, a Luxembourg company owned by funds advised by the British investment firm Permira, as part of the initial public offering of the British footwear company. With the exercise of the option, an additional 52,500,005 ...
Your membership benefits:
If you aren’t ready to subscribe now, choose the 30 day trial for 1€. To continue reading this article REGISTER NOW.